Can Entresto (sacubitril/valsartan) be broken in half?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Entresto Be Split or Broken in Half?

No, Entresto (sacubitril/valsartan) tablets should not be broken, crushed, or split—they must be swallowed whole. This is critical because the medication is formulated as a specific supramolecular complex that requires intact delivery for proper absorption and efficacy 1.

Why Entresto Cannot Be Split

  • Formulation integrity: Entresto is a supramolecular sodium salt complex combining sacubitril (a neprilysin inhibitor prodrug) and valsartan (an ARB) in precise ratios that must remain intact 1
  • Absorption requirements: The medication is absorbed primarily in the stomach and proximal small bowel, and altering the tablet structure could compromise bioavailability 2
  • Dosing precision: The drug requires twice-daily administration at specific doses (24/26 mg, 49/51 mg, or 97/103 mg) that have been validated in clinical trials 3

Available Dosing Options

If a lower dose is needed, use the commercially available lower-strength tablets rather than splitting higher-strength tablets 3:

  • Starting dose: 49/51 mg twice daily (or 24/26 mg twice daily in certain patients)
  • Target dose: 97/103 mg twice daily
  • Titration: Increase every 2-4 weeks as tolerated 3

Clinical Considerations

  • Dose adjustments: If blood pressure, renal function, or tolerability issues arise, switch to a lower commercially available strength rather than splitting tablets 2, 4
  • Uptitration challenges: Only 27% of patients achieve target dose within 6 months in real-world practice, often due to side effects or slower titration—this should be managed by using appropriate tablet strengths, not by splitting 4
  • Monitoring: Check blood pressure, heart rate, renal function, and potassium 1-2 weeks after initiation or dose changes 2, 5

Common Pitfall to Avoid

Do not attempt to "customize" doses by splitting tablets—this practice undermines the medication's pharmacokinetic profile and may result in subtherapeutic dosing or unpredictable absorption 2, 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dosing of Entresto in Heart Failure Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Concurrent Use of Coreg and Entresto in Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Should Entresto (sacubitril/valsartan) be dosed twice daily, and are there situations where it can be dosed once daily?
Is Entresto (sacubitril/valsartan) a good choice for treatment of Congestive Heart Failure (CHF) in patients with hepatic disease?
Can I split an Entresto (sacubitril/valsartan) 49/51 tablet in half?
Can Entresto (sacubitril/valsartan) help with heart failure, specifically heart failure with reduced ejection fraction (HFrEF)?
When to switch a patient from lisinopril (Angiotensin-Converting Enzyme Inhibitor) to Entresto (sacubitril/valsartan)?
What are the initial steps to manage a hamstring strain?
Can a capsule endoscopy be used to diagnose an elderly patient with diarrhea, abdominal cramping, and hematochezia who prefers to avoid a colonoscopy?
Is medical necessity met for percutaneous implantation of neurostimulator electrode array, epidural (63650 x(2)) and implantable neurostimulator (L8680 x(16)) for a patient with causalgia of the left lower limb (G57.72) and complex regional pain syndrome I of the right lower limb (G90.521)?
What is the management approach for a patient with EKG (electrocardiogram) inferior Q waves?
What are the next steps for a 41-year-old female with persistent steatorrhea (fatty stools) and normal lab results, including Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), thyroid function, iron and ferritin levels, amylase and lipase, and a normal abdominal ultrasound, to rule out pancreatic malignancy?
What is the recommended approach for ultrasound-guided chest tube thoracostomy (chest tube insertion) versus pigtail catheter insertion for pleural space drainage?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.